A detailed history of Sunpointe, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sunpointe, LLC holds 1,004 shares of LLY stock, worth $799,465. This represents 0.73% of its overall portfolio holdings.

Number of Shares
1,004
Previous 745 34.77%
Holding current value
$799,465
Previous $675 Million 31.87%
% of portfolio
0.73%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $199,984 - $248,645
259 Added 34.77%
1,004 $889 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $59,439 - $74,541
82 Added 12.37%
745 $675 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $20,727 - $27,729
35 Added 5.57%
663 $516 Million
Q4 2023

Feb 20, 2024

BUY
$525.19 - $619.13 $329,819 - $388,813
628 New
628 $366 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.